Encompass Health Corporation Net Income (Loss) Available to Common Stockholders, Diluted
Encompass Health Corporation (EHC) reported Net Income (Loss) Available to Common Stockholders, Diluted of $153.90 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAvailableToCommonStockholdersDiluted · last filed 2026-08-07
- Encompass Health Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2026-06-30 was $153.90M, a 8.30% increase year-over-year.
- Encompass Health Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2026-03-31 was $194.50M, a 28.38% increase year-over-year.
- Encompass Health Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2025-12-31 was $146.10M, a 20.84% increase year-over-year.
- Encompass Health Corporation net income (loss) available to common stockholders, diluted for the quarter ending 2025-09-30 was $126.50M, a 16.91% increase year-over-year.
- Encompass Health Corporation net income (loss) available to common stockholders, diluted for fiscal 2025 was $566.20M, a 24.25% increase from fiscal 2024.
- Encompass Health Corporation net income (loss) available to common stockholders, diluted for fiscal 2024 was $455.70M, a 29.46% increase from fiscal 2023.
- Encompass Health Corporation net income (loss) available to common stockholders, diluted for fiscal 2023 was $352.00M, a 29.89% increase from fiscal 2022.
- Encompass Health Corporation net income (loss) available to common stockholders, diluted for fiscal 2022 was $271.00M, a 34.26% decline from fiscal 2021.
| Period end | Net Income (Loss) Available to Common Stockholders, Diluted 3 month | Net Income (Loss) Available to Common Stockholders, Diluted 6 month | Net Income (Loss) Available to Common Stockholders, Diluted 9 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month | Net Income (Loss) Available to Common Stockholders, Diluted 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-30 | $153.90M 10-Q · filed 2026-08-07 | $348.40M 10-Q · filed 2026-08-07 | $494.50M derived: sum of 3 quarters · filed 2026-08-07 | $621.00M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2026-03-31 | $194.50M 10-Q · filed 2026-05-01 | $340.60M derived: sum of 2 quarters · filed 2026-05-01 | $467.10M derived: sum of 3 quarters · filed 2026-05-01 | $609.20M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-12-31 | $146.10M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $272.60M derived: sum of 2 quarters · filed 2026-02-26 | $414.70M derived: sum of 3 quarters · filed 2026-08-07 | $566.20M 10-K · filed 2026-02-26 | |
| 2025-09-30 | $126.50M 10-Q · filed 2025-10-31 | $268.60M derived: sum of 2 quarters · filed 2026-08-07 | $420.10M 10-Q · filed 2025-10-31 | $541.00M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-06-30 | $142.10M 10-Q · filed 2026-08-07 | $293.60M 10-Q · filed 2026-08-07 | $414.50M derived: sum of 3 quarters · filed 2026-08-07 | $522.70M derived: sum of 4 quarters · filed 2026-08-07 | |
| 2025-03-31 | $151.50M 10-Q · filed 2026-05-01 | $272.40M derived: sum of 2 quarters · filed 2026-05-01 | $380.60M derived: sum of 3 quarters · filed 2026-05-01 | $494.70M derived: sum of 4 quarters · filed 2026-05-01 | |
| 2024-12-31 | $120.90M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $229.10M derived: sum of 2 quarters · filed 2026-02-26 | $343.20M derived: sum of 3 quarters · filed 2026-02-26 | $455.70M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $108.20M 10-Q · filed 2025-10-31 | $222.30M derived: sum of 2 quarters · filed 2025-10-31 | $334.80M 10-Q · filed 2025-10-31 | $422.40M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-06-30 | $114.10M 10-Q · filed 2025-08-06 | $226.60M 10-Q · filed 2025-08-06 | $314.20M derived: sum of 3 quarters · filed 2026-02-26 | $399.50M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2024-03-31 | $112.50M 10-Q · filed 2025-05-01 | $200.10M derived: sum of 2 quarters · filed 2026-02-26 | $285.40M derived: sum of 3 quarters · filed 2026-02-26 | $376.80M derived: sum of 4 quarters · filed 2026-02-26 | |
| 2023-12-31 | $87.60M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $172.90M derived: sum of 2 quarters · filed 2026-02-26 | $264.30M derived: sum of 3 quarters · filed 2026-02-26 | $352.00M 10-K · filed 2026-02-26 | |
| 2023-09-30 | $85.30M 10-Q · filed 2024-11-01 | $176.70M derived: sum of 2 quarters · filed 2024-11-01 | $264.40M 10-Q · filed 2024-11-01 | $353.80M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-06-30 | $91.40M 10-Q · filed 2024-08-06 | $179.10M 10-Q · filed 2024-08-06 | $268.50M derived: sum of 3 quarters · filed 2025-02-28 | $313.90M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2023-03-31 | $87.70M 10-Q · filed 2024-05-02 | $177.10M derived: sum of 2 quarters · filed 2025-02-28 | $222.50M derived: sum of 3 quarters · filed 2025-02-28 | $271.20M derived: sum of 4 quarters · filed 2025-02-28 | |
| 2022-12-31 | $89.40M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-28 | $134.80M derived: sum of 2 quarters · filed 2025-02-28 | $183.50M derived: sum of 3 quarters · filed 2025-02-28 | $271.00M 10-K · filed 2025-02-28 | |
| 2022-09-30 | $45.40M 10-Q · filed 2023-11-01 | $94.10M derived: sum of 2 quarters · filed 2023-11-01 | $181.60M 10-Q · filed 2023-11-01 | $273.20M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-06-30 | $48.70M 10-Q · filed 2023-08-04 | $136.20M 10-Q · filed 2023-08-04 | $227.80M derived: sum of 3 quarters · filed 2024-02-28 | $327.80M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2022-03-31 | $87.50M 10-Q · filed 2023-05-03 | $179.10M derived: sum of 2 quarters · filed 2024-02-28 | $279.10M derived: sum of 3 quarters · filed 2024-02-28 | $392.40M derived: sum of 4 quarters · filed 2024-02-28 | |
| 2021-12-31 | $91.60M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $191.60M derived: sum of 2 quarters · filed 2024-02-28 | $304.90M derived: sum of 3 quarters · filed 2024-02-28 | $412.20M 10-K · filed 2024-02-28 | |
| 2021-09-30 | $100.00M 10-Q · filed 2022-11-02 | $213.30M derived: sum of 2 quarters · filed 2022-11-02 | $320.60M 10-Q · filed 2022-11-02 | $406.60M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-06-30 | $113.30M 10-Q · filed 2022-08-04 | $220.60M 10-Q · filed 2022-08-04 | $306.60M derived: sum of 3 quarters · filed 2023-02-27 | $384.30M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2021-03-31 | $107.30M 10-Q · filed 2022-05-03 | $193.30M derived: sum of 2 quarters · filed 2023-02-27 | $271.00M derived: sum of 3 quarters · filed 2023-02-27 | $304.50M derived: sum of 4 quarters · filed 2023-02-27 | |
| 2020-12-31 | $86.00M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27 | $163.70M derived: sum of 2 quarters · filed 2023-02-27 | $197.20M derived: sum of 3 quarters · filed 2023-02-27 | $284.20M 10-K · filed 2023-02-27 | |
| 2020-09-30 | $77.70M 10-Q · filed 2021-11-02 | $111.20M derived: sum of 2 quarters · filed 2021-11-02 | $198.20M 10-Q · filed 2021-11-02 | $265.80M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-06-30 | $33.50M 10-Q · filed 2021-08-03 | $120.50M 10-Q · filed 2021-08-03 | $188.10M derived: sum of 3 quarters · filed 2022-02-25 | $285.70M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2020-03-31 | $87.00M 10-Q · filed 2021-05-04 | $154.60M derived: sum of 2 quarters · filed 2022-02-25 | $252.20M derived: sum of 3 quarters · filed 2022-02-25 | $343.40M derived: sum of 4 quarters · filed 2022-02-25 | |
| 2019-12-31 | $67.60M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-25 | $165.20M derived: sum of 2 quarters · filed 2022-02-25 | $256.40M derived: sum of 3 quarters · filed 2022-02-25 | $358.70M 10-K · filed 2022-02-25 | |
| 2019-09-30 | $97.60M 10-Q · filed 2020-11-02 | $188.80M derived: sum of 2 quarters · filed 2020-11-02 | $291.10M 10-Q · filed 2020-11-02 | $319.20M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-06-30 | $91.20M 10-Q · filed 2020-07-31 | $193.50M 10-Q · filed 2020-07-31 | $221.60M derived: sum of 3 quarters · filed 2021-02-26 | $310.20M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2019-03-31 | $102.30M 10-Q · filed 2020-05-11 | $130.40M derived: sum of 2 quarters · filed 2021-02-26 | $219.00M derived: sum of 3 quarters · filed 2021-02-26 | $310.80M derived: sum of 4 quarters · filed 2021-02-26 | |
| 2018-12-31 | $28.10M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26 | $116.70M derived: sum of 2 quarters · filed 2021-02-26 | $208.50M derived: sum of 3 quarters · filed 2021-02-26 | $292.30M 10-K · filed 2021-02-26 | |
| 2018-09-30 | $88.60M 10-Q · filed 2019-10-31 | $180.40M derived: sum of 2 quarters · filed 2019-10-31 | $264.20M 10-Q · filed 2019-10-31 | $339.60M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-06-30 | $91.80M 10-Q · filed 2019-07-31 | $175.60M 10-Q · filed 2019-07-31 | $251.00M derived: sum of 3 quarters · filed 2020-02-27 | $316.90M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2018-03-31 | $83.80M 10-Q · filed 2019-05-01 | $159.20M derived: sum of 2 quarters · filed 2020-02-27 | $225.10M derived: sum of 3 quarters · filed 2020-02-27 | $296.40M derived: sum of 4 quarters · filed 2020-02-27 | |
| 2017-12-31 | $75.40M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $141.30M derived: sum of 2 quarters · filed 2020-02-27 | $212.60M derived: sum of 3 quarters · filed 2020-02-27 | $281.90M 10-K · filed 2020-02-27 | $267.10M 10-K · filed 2018-02-28 |
| 2017-09-30 | $65.90M 10-Q · filed 2018-10-31 | $137.20M derived: sum of 2 quarters · filed 2018-10-31 | $206.50M 10-Q · filed 2018-10-31 | $274.30M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-06-30 | $71.30M 10-Q · filed 2018-08-02 | $140.60M 10-Q · filed 2018-08-02 | $208.40M derived: sum of 3 quarters · filed 2019-02-27 | $272.50M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2017-03-31 | $69.30M 10-Q · filed 2018-05-02 | $137.10M derived: sum of 2 quarters · filed 2019-02-27 | $201.20M derived: sum of 3 quarters · filed 2019-02-27 | $266.20M derived: sum of 4 quarters · filed 2019-02-27 | |
| 2016-12-31 | $67.80M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-27 | $131.90M derived: sum of 2 quarters · filed 2019-02-27 | $196.90M derived: sum of 3 quarters · filed 2019-02-27 | $257.30M 10-K · filed 2019-02-27 | |
| 2016-09-30 | $64.10M 10-Q · filed 2017-10-31 | $129.10M derived: sum of 2 quarters · filed 2017-10-31 | $189.50M 10-Q · filed 2017-10-31 | $238.90M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-06-30 | $65.00M 10-Q · filed 2017-08-02 | $125.40M 10-Q · filed 2017-08-02 | $174.80M derived: sum of 3 quarters · filed 2018-02-28 | $227.90M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2016-03-31 | $60.40M 10-Q · filed 2017-04-28 | $109.80M derived: sum of 2 quarters · filed 2018-02-28 | $162.90M derived: sum of 3 quarters · filed 2018-02-28 | $208.10M derived: sum of 4 quarters · filed 2018-02-28 | |
| 2015-12-31 | $49.40M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28 | $102.50M derived: sum of 2 quarters · filed 2018-02-28 | $147.70M derived: sum of 3 quarters · filed 2018-02-28 | $192.50M 10-K · filed 2018-02-28 | |
| 2015-09-30 | $53.10M 10-Q · filed 2016-10-28 | $98.30M derived: sum of 2 quarters · filed 2016-10-28 | $143.10M 10-Q · filed 2016-10-28 | $187.40M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2015-06-30 | $45.20M 10-Q · filed 2016-07-29 | $90.00M 10-Q · filed 2016-07-29 | $134.30M derived: sum of 3 quarters · filed 2017-09-19 | $186.70M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2015-03-31 | $44.80M 10-Q · filed 2016-04-28 | $89.10M derived: sum of 2 quarters · filed 2017-09-19 | $141.50M derived: sum of 3 quarters · filed 2017-09-19 | $226.90M derived: sum of 4 quarters · filed 2017-09-19 | |
| 2014-12-31 | $44.30M derived: 8-K 12 month − 10-Q 9 month · filed 2017-09-19 | $96.70M derived: sum of 2 quarters · filed 2017-09-19 | $182.10M derived: sum of 3 quarters · filed 2017-09-19 | $231.00M 8-K · filed 2017-09-19 | |
| 2014-09-30 | $52.40M 10-Q · filed 2015-10-29 | $137.80M derived: sum of 2 quarters · filed 2015-10-29 | $186.70M 10-Q · filed 2015-10-29 | $236.60M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-06-30 | $85.40M 10-Q · filed 2015-07-30 | $134.30M 10-Q · filed 2015-07-30 | $184.20M derived: sum of 3 quarters · filed 2016-02-25 | $242.40M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2014-03-31 | $48.90M 10-Q · filed 2015-05-01 | $98.80M derived: sum of 2 quarters · filed 2016-02-25 | $157.00M derived: sum of 3 quarters · filed 2016-02-25 | $322.20M derived: sum of 4 quarters · filed 2016-02-25 | |
| 2013-12-31 | $49.90M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-25 | $108.10M derived: sum of 2 quarters · filed 2016-02-25 | $273.30M derived: sum of 3 quarters · filed 2016-02-25 | $324.60M 10-K · filed 2016-02-25 | |
| 2013-09-30 | $58.20M 10-Q · filed 2014-10-28 | $223.40M derived: sum of 2 quarters · filed 2014-10-28 | $274.70M 10-Q · filed 2014-10-28 | $321.70M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-06-30 | $165.20M 10-Q · filed 2014-07-29 | $216.50M 10-Q · filed 2014-07-29 | $263.50M derived: sum of 3 quarters · filed 2015-03-02 | $310.60M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2013-03-31 | $51.30M 10-Q · filed 2014-04-29 | $98.30M derived: sum of 2 quarters · filed 2015-03-02 | $145.40M derived: sum of 3 quarters · filed 2015-03-02 | $192.10M derived: sum of 4 quarters · filed 2015-03-02 | |
| 2012-12-31 | $47.00M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $94.10M derived: sum of 2 quarters · filed 2015-03-02 | $140.80M derived: sum of 3 quarters · filed 2015-03-02 | $185.00M 10-K · filed 2015-03-02 | |
| 2012-09-30 | $47.10M 10-Q · filed 2013-10-29 | $93.80M derived: sum of 2 quarters · filed 2013-10-29 | $138.00M 10-Q · filed 2013-10-29 | ||
| 2012-06-30 | $46.70M 10-Q · filed 2013-07-30 | $90.90M 10-Q · filed 2013-07-30 | |||
| 2012-03-31 | $44.20M 10-Q · filed 2013-04-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |